Malignant hypertension: a type of IgA nephropathy manifestation with poor prognosis Ángel M. Sevillano-Prieto, Ángel M. Sevillano, Jimena Cabrera-Betancor, Jimena Cabrera, Eduardo Gutiérrez-Martínez, Eduardo Gutiérrez, Enrique Morales-Ruiz, Enrique Morales, Evangelina Mérida-Herrero, Evangelina Mérida, Teresa Cavero-Escribano, Ana Huerta, Eduardo Hernández-Martínez, Teresa Cavero, Juan A. Moreno-Gutiérrez, Eduardo Hernández, Manuel Praga-Terente, Juan A. Moreno, Manuel Praga

Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population Luis Martín-Penagos, Adalberto Benito, María Victoria Oviedo, Covadonga López del Moral Cuesta, Javier Martín López, Javier Gómez Román, Raquel López-Mejías, Gema Fernandez-Fresnedo, Juan Carlos Ruíz San Millán, Emilio Rodrigo Calabia

IGA nephropathy – Are intravenous steroid pulses more effective than oral steroids in relapse prevention? Ivo Laranjinha, Patrícia Matias, João Cassis, Patrícia Branco, Sância Ramos, José Diogo Barata, André Weigert